UBS Lux Equity Fund Biotech USD vs BNP Paribas China Equity

UBS Lux Equity Fund Biotech USD vs BNP Paribas China Equity

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    16

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with BNP Paribas China Equity, we have 22 holdings where Alibaba Group Holding Ltd is the largest holding (9.57), followed by Tencent (9.35) and Xiaomi (6.61).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and BNP Paribas China Equity.

UBS Lux Equity Fund Biotech USD BNP Paribas China Equity
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Alibaba Group Holding Ltd
China
9.57 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Tencent Holdings Ltd
China
9.35 %
3. Moderna Inc
9.21 %
3. Xiaomi
China
6.61 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Industrial and Commercial Bank of China Ltd Class H
China
4.22 %
5. AbbVie Inc
USA
5.53 %
5. Pop Mart International Group Ltd
China
4.17 %
6. Gilead Sciences Inc
USA
4.66 %
6. Meituan Class B
China
3.16 %
7. Amgen Inc
4.3 %
7. Trip.com Group Ltd
Singapore
2.91 %
8. BioNTech SE
4.13 %
8. Ping An Insurance Co
China
2.71 %
9. Karuna Therapeutics Inc
3.75 %
9. NetEase ADR
China
2.41 %
10. Royalty Pharma Plc
3.37 %
10. KE Holdings Inc ADR
China
2.4 %
- 11. JD.com Inc
China
2.22 %
- 12. Taiwan Semiconductor Manufacturing Company
Taiwan
1.7 %
- 13. Pinduoduo Inc
China
1.68 %
- 14. China Yangtze Power Co Ltd Class A
China
1.64 %
- 15. BYD Co Ltd Class H
China
1.52 %
- 16. Sunny Optical Technology Company Ltd
China
1.27 %

The list of fund holdings was last updated on June 6, 2025.